Acute & chronic heart failure

Heart Failure Mismanagement in clinical negligence claims.

Expert witness reports on delayed diagnosis, suboptimal treatment and inadequate monitoring of heart failure. Claims typically turn on whether symptoms were recognised and whether guideline-directed medical therapy was initiated and titrated to target.

  • HFrEF claims
  • Delayed heart failure diagnosis
  • Congestive heart failure negligence
  • Bolam · Bolitho · Montgomery
what we cover

Heart failure mismanagement and the legal questions it raises.

Heart failure mismanagement claims typically arise where diagnosis is delayed, treatment is suboptimal, or monitoring fails to follow accepted standards. Our cardiologists assess whether the clinical decisions met the Bolam and Bolitho standard and whether earlier intervention would, on the balance of probabilities, have altered the outcome.

Instructions often focus on whether symptoms of breathlessness, fatigue or oedema were recognised as heart failure, whether the appropriate investigations (echocardiography, NT-proBNP) were requested, and whether guideline-directed medical therapy was initiated and titrated. Reports measure the decisions against NICE NG106 on chronic heart failure in adults and the ESC heart failure guidelines.

  • Breach questions address whether symptoms were correctly attributed to heart failure, whether NT-proBNP testing or echocardiography were appropriately requested, and whether guideline-directed medical therapy was initiated and titrated.
  • Causation questions examine whether earlier diagnosis or optimised therapy would, on the balance of probabilities, have prevented hospitalisation or reduced the degree of left ventricular dysfunction.
  • Monitoring failures include inadequate follow-up of NT-proBNP trends, failure to escalate diuretic therapy in fluid overload, and missed opportunities to refer for device therapy (ICD, CRT) where indicated.
  • Apportionment arises where pre-existing comorbidities contributed to the outcome alongside the alleged mismanagement, with material contribution analysis then applied to causation.
Clinical scope

The clinical questions our cardiologists answer.

Reports address the cardiology decisions in issue against current guidance and the Bolam and Bolitho standard.

Included in scope

Questions addressed

  • Whether symptoms of breathlessness, fatigue or peripheral oedema were correctly attributed to heart failure, and whether the differential diagnosis excluded other causes.
  • Whether NT-proBNP testing or echocardiography were requested in line with NICE NG106, and whether results were acted on appropriately.
  • Whether guideline-directed medical therapy (ACE inhibitors or ARNI, beta-blockers, MRAs, SGLT2 inhibitors) was initiated and titrated to target doses, and whether contraindications were appropriately documented.
  • Whether monitoring of symptoms, renal function and NT-proBNP levels was sufficient to detect deterioration and adjust therapy in a timely manner.
  • Whether, on the balance of probabilities, earlier diagnosis or optimised therapy would have altered the clinical outcome, including hospitalisation rates and left ventricular function.
Out of scope

Not covered without separate instruction

Common cases

Common scenarios we report on.

These patterns recur in heart failure claims, most turning on primary or secondary care decisions.

  • Primary care · Misdiagnosis

    Heart failure misdiagnosis as COPD or obesity

    Patient presents with breathlessness and fatigue. Symptoms are attributed to chronic obstructive pulmonary disease or obesity without NT-proBNP testing or echocardiography. Heart failure diagnosis is delayed by months or years. The report addresses whether NICE NG106 thresholds for investigation were met and whether earlier diagnosis would have altered the trajectory.

    Often paired with: Breach of Duty Causation

  • Secondary care · Delayed diagnosis

    Delayed heart failure diagnosis during acute admission

    Patient admitted with acute pulmonary oedema. NT-proBNP is elevated but echocardiography is not performed during admission, and the discharge summary does not mention heart failure. Readmission follows weeks later. The report examines whether the admission presented an opportunity for diagnosis and whether the ESC acute heart failure guidance was followed.

    Often paired with: Breach of Duty Causation

  • Primary care · Suboptimal therapy

    Inadequate titration of guideline-directed medical therapy

    Known HFrEF with left ventricular ejection fraction 30%. ACE inhibitor and beta-blocker initiated but not titrated to target doses over 12 months. No SGLT2 inhibitor prescribed. The patient experiences recurrent hospitalisations for fluid overload. The report addresses whether therapy fell below the accepted standard and whether optimised therapy would have reduced hospitalisation rates.

    Often paired with: Screening & Merits Breach of Duty

  • Secondary care · Device referral

    Missed referral for ICD or CRT

    Patient with HFrEF and left ventricular ejection fraction 28% despite optimal medical therapy. No referral was made for implantable cardioverter-defibrillator or cardiac resynchronisation therapy, and sudden cardiac death followed. The report tests whether the referral threshold for device therapy was met and whether earlier intervention would have altered the outcome.

    Often paired with: Causation Condition & Prognosis

Approaching a deadline?

Instruct an expert in heart failure.

Send a short note on the alleged failings with the records bundle. Quotation returned the same working day; fast-track available where the trial window or limitation deadline requires it.

GMC-registered consultants Fixed fee where the bundle allows LAA rates available